4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB

(E-pub Ahead of Print)

Author(s): Marcus Vinicius Nora de Souza*, Thais Cristina Mendonça Nogueira.

Journal Name: Current Topics in Medicinal Chemistry

Become EABM
Become Reviewer


Nowadays, tuberculosis (TB) is an important global public health problem, being responsible for millions of TB-related deaths worldwide. Due to the increased number of cases and resistance of Mycobacterium tuberculosis to all drugs used to the treatment of this disease, we desperately need new drugs and strategies that could reduce treatment time with fewer side effects, reduced cost and highly active drugs against resistance strains and latent disease. Considering that, 4H-1,3-benzothiazin-4-one is a promising class of antimycobacterial agents in special against TB-resistance strains being the aim of this review¬ the discussion of different aspects of this chemical class such as synthesis, mechanism of action, medicinal chemistry and combination with other drugs.

Keywords: Tuberculosis, drugs, 4H-1, 3-benzothiazin-4-one, synthesis

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1568026619666190305130809
Price: $95